FASEB J. : Fast, Stable Macromolecular Detection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.09-135160.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Buy
Right arrow All Versions of this Article:
fj.09-135160v1
23/12/4288    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayer, S.
Right arrow Articles by Pap, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayer, S.
Right arrow Articles by Pap, T.
(The FASEB Journal. 2009;23:4288-4298.)
© 2009 FASEB

PI3K{gamma} regulates cartilage damage in chronic inflammatory arthritis

Silvia Hayer*,1, Noreen Pundt{dagger},1, Marvin A. Peters{dagger}, Christina Wunrau{dagger}, Inga Kühnel{dagger}, Katja Neugebauer{dagger}, Simon Strietholt{dagger}, Jochen Zwerina{ddagger}, Adelheid Korb§, Josef Penninger||, Leo A. B. Joosten, Steffen Gay#, Thomas Rückle**, Georg Schett{ddagger},1,2 and Thomas Pap{dagger},1

* Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria;

{dagger} Division of Molecular Medicine of Musculoskeletal Tissue and

§ Department of Internal Medicine, Nephrology, and Rheumatology, University Hospital Muenster, Muenster, Germany;

{ddagger} Department of Internal Medicine III, University Erlangen-Nuremberg, Erlangen-Nuremberg, Germany;

|| Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria;

Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;

# Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland; and

** Operational Excellence, Merck Serono International, Geneva, Switzerland

2 Correspondence: Department of Internal Medicine III, University of Erlangen, Krankenhausstrasse 12, 91054 Erlangen, Germany. E-mail: georg.schett{at}uk-erlangen.de

The {gamma} isoform of phosphoinositide 3-kinase (PI3K{gamma}) has been viewed as restricted to leukocytes mediating the regulation of chemokine-induced migration and recruitment of neutrophils, monocytes, and macrophages. In line with the observation that PI3K{gamma}-deficient mice display defects in adaptive immunity, inhibition of PI3K{gamma} reduces synovial inflammation in the collagen-induced arthritis mouse model of inflammatory arthritis [rheumatoid arthritis (RA)], which has been attributed to reduced influx of inflammatory cells. Challenging the concept of leukocyte-restricted PI3K{gamma} function, we report here a novel, nonredundant function of PI3K{gamma} as an important regulator of fibroblast-induced cartilage destruction during chronic destructive arthritis. We show that in human tumor necrosis factor transgenic mice, the loss of PI3K{gamma} leads to a milder inflammatory arthritis. Interestingly, PI3K{gamma} deficiency does not alter the recruitment of inflammatory cells, but significantly reduces cartilage damage through reduced expression of matrix metalloproteinases in fibroblasts and chondrocytes. In vitro analyses demonstrate that the decreased invasiveness of fibroblasts is mediated by reduced phosphorylation of Akt and extracellular signal-regulated kinase. Using a PI3K{gamma} specific inhibitor, these data are confirmed in human synovial fibroblasts from patients with RA who exhibit a disease-specific up-regulation of PI3K{gamma}. Our data indicate that in addition to mediating the recruitment of inflammatory cells, PI3K{gamma} is an important regulator of fibroblast-mediated joint destruction in RA and suggest that specific inhibitors of PI3K{gamma} will interfere with the activation of RA synovial fibroblasts and reduce cartilage destruction in RA.—Hayer, S., Pundt, N., Peters, M. A., Wunrau, C., Kühnel, I., Neugebauer, K., Strietholt, S., Zwerina, J., Korb, A., Penninger, J., Joosten, L. A. B., Gay, S., Rückle, T., Schett, G., Pap, T. Phosphatidylinositol 3-kinase-{gamma} regulates cartilage damage in chronic inflammatory arthritis.


Key Words: inflammation • rheumatoid arthritis • synovial fibroblast • chondrocytes • signaling







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.